1.
Minerva Endocrinol
; 9(2): 261-3, 1984.
Artigo
em Italiano
| MEDLINE
| ID: mdl-6503910
2.
Clin Ter
; 110(4): 353-8, 1984 Aug 31.
Artigo
em Italiano
| MEDLINE
| ID: mdl-6237871
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias do Colo/tratamento farmacológico , Neoplasias Retais/tratamento farmacológico , Neoplasias Gástricas/tratamento farmacológico , Adulto , Idoso , Doxorrubicina/administração & dosagem , Avaliação de Medicamentos , Feminino , Fluoruracila/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Mitomicina , Mitomicinas/administração & dosagem
3.
Ric Clin Lab
; 14(2): 211-20, 1984.
Artigo
em Inglês
| MEDLINE
| ID: mdl-6091246
RESUMO
The effect of administration of a synthetic ACTH analogue (ACTH 1-17, Synchrodyn) in the chemotherapy of advanced-phase solid tumors was studied. In this preliminary report the following data are evaluated: response rate; occurrence of toxic effects; performance status of patients; several immunological parameters. The administration of Synchrodyn seems mainly to influence the lymphocyte subpopulations and the occurrence of toxic effects. A final evaluation of the role that may be played by chronotherapy in the treatment of tumors must await further studies on the clinical response and tolerance.